graph TB
    Start([Hypothyroidism Population]) --> Split{Etiology}
    
    Split -->|Autoimmune| AI[Autoimmune Hypothyroidism<br/>Hashimoto's Thyroiditis<br/>Anti-TPO/Anti-Tg Positive]
    Split -->|Non-Autoimmune| NAI[Non-Autoimmune Hypothyroidism<br/>Iatrogenic/Congenital/Idiopathic<br/>Antibody Negative]
    
    %% Shared Features
    AI --> Shared1[Shared Clinical Features]
    NAI --> Shared1
    
    Shared1 --> S1[Elevated TSH<br/>Low Free T4/T3]
    Shared1 --> S2[Fatigue & Cold Intolerance]
    Shared1 --> S3[Weight Changes]
    Shared1 --> S4[Cognitive Slowing]
    Shared1 --> S5[Depressive Symptoms<br/>Baseline Level]
    
    %% Autoimmune Specific Pathway
    AI --> AIPath[Autoimmune-Specific Mechanisms]
    
    AIPath --> AIM1[Immune Dysregulation]
    AIPath --> AIM2[Chronic Inflammation]
    AIPath --> AIM3[Anti-Thyroid Antibodies]
    AIPath --> AIM4[Potential CNS Cross-Reactivity]
    
    AIM1 --> AIClin[Enhanced Clinical Features]
    AIM2 --> AIClin
    AIM3 --> AIClin
    AIM4 --> AIClin
    
    AIClin --> AIC1[Greater Disease Variability]
    AIClin --> AIC2[Fluctuating Symptoms]
    AIClin --> AIC3[Ultrasound: Heterogeneous Echo]
    
    %% Autoimmune Psychiatric Features
    AIPath --> AIPsych[Enhanced Psychiatric Burden]
    
    AIPsych --> AIP1[Higher Depression Severity<br/>⬆️ BDI-II/HAM-D Scores]
    AIPsych --> AIP2[Greater Anxiety Levels<br/>⬆️ GAD-7/HAM-A Scores]
    AIPsych --> AIP3[More Cognitive Complaints<br/>⬆️ Subjective Impairment]
    AIPsych --> AIP4[Persistent Fatigue<br/>Independent of TSH]
    AIPsych --> AIP5[Treatment-Resistant Symptoms]
    
    %% Psychosis Pathway - Autoimmune
    AIPsych --> AIPsy[Psychotic Manifestations<br/>HIGHER PREVALENCE]
    
    AIPsy --> AIPS1[Attenuated Psychotic Symptoms<br/>Prevalence: 15-25%]
    AIPsy --> AIPS2[Frank Psychotic Episodes<br/>Prevalence: 5-10%]
    AIPsy --> AIPS3[Hashimoto's Encephalopathy<br/>SREAT Syndrome<br/>Prevalence: 2-5%]
    
    AIPS1 --> PSProfile1[Symptom Profile:<br/>Autoimmune Pattern]
    AIPS2 --> PSProfile1
    AIPS3 --> PSProfile1
    
    PSProfile1 --> PP1A[Perceptual Disturbances<br/>⬆️ Visual/Auditory Hallucinations]
    PSProfile1 --> PP1B[Paranoid Ideation<br/>⬆️ Persecutory Themes]
    PSProfile1 --> PP1C[Confusional States<br/>⬆️ Delirium-like Features]
    PSProfile1 --> PP1D[Thought Disorder<br/>Disorganization]
    PSProfile1 --> PP1E[Affective Symptoms<br/>Depression + Psychosis]
    
    AIPS3 --> HE[Hashimoto's Encephalopathy<br/>Unique Features]
    
    HE --> HE1[Elevated Anti-TPO Titers<br/>>1000 IU/mL]
    HE --> HE2[Often Normal Thyroid Function]
    HE --> HE3[Neurological Signs<br/>Tremor, Myoclonus, Ataxia]
    HE --> HE4[EEG Abnormalities<br/>Diffuse Slowing]
    HE --> HE5[Steroid-Responsive<br/>Dramatic Improvement]
    HE --> HE6[Rapid Onset<br/>Days to Weeks]
    HE --> HE7[Fluctuating Course<br/>Relapsing-Remitting]
    
    %% Autoimmune Mechanisms for Psychosis
    AIPsy --> AIMech[Proposed Mechanisms]
    
    AIMech --> AM1[Neuroinflammation<br/>⬆️ IL-6, TNF-α, CRP]
    AIMech --> AM2[BBB Disruption<br/>Antibody CNS Penetration]
    AIMech --> AM3[Anti-Neuronal Antibodies<br/>Cross-Reactivity]
    AIMech --> AM4[Cytokine-Mediated<br/>Neurotransmitter Dysregulation]
    AIMech --> AM5[Cerebral Hypoperfusion<br/>Vascular Changes]
    
    %% Non-Autoimmune Specific Pathway
    NAI --> NAIPath[Non-Autoimmune Mechanisms]
    
    NAIPath --> NAIM1[Pure Hormone Deficiency]
    NAIPath --> NAIM2[No Immune Activation]
    NAIPath --> NAIM3[Structural/Iatrogenic Causes]
    
    NAIM1 --> NAIClin[Clinical Features]
    NAIM2 --> NAIClin
    NAIM3 --> NAIClin
    
    NAIClin --> NAIC1[More Stable Course]
    NAIClin --> NAIC2[Predictable Response to Treatment]
    NAIClin --> NAIC3[Ultrasound: Normal or Atrophic]
    
    %% Non-Autoimmune Psychiatric Features
    NAIPath --> NAIPsych[Psychiatric Manifestations<br/>LOWER BURDEN]
    
    NAIPsych --> NAIP1[Moderate Depression<br/>⬇️ Severity vs Autoimmune]
    NAIPsych --> NAIP2[Moderate Anxiety<br/>⬇️ Severity vs Autoimmune]
    NAIPsych --> NAIP3[Cognitive Slowing<br/>Hormone-Dependent]
    NAIPsych --> NAIP4[Fatigue<br/>Correlates with TSH]
    NAIPsych --> NAIP5[Better Treatment Response<br/>Symptoms Resolve with T4]
    
    %% Psychosis Pathway - Non-Autoimmune
    NAIPsych --> NAIPsy[Psychotic Manifestations<br/>LOWER PREVALENCE]
    
    NAIPsy --> NAIPS1[Attenuated Symptoms<br/>Prevalence: 5-10%]
    NAIPsy --> NAIPS2[Frank Psychosis<br/>Prevalence: 2-5%]
    NAIPsy --> NAIPS3[Myxedema Madness<br/>Severe Hypothyroidism<br/>Prevalence: <2%]
    
    NAIPS1 --> PSProfile2[Symptom Profile:<br/>Non-Autoimmune Pattern]
    NAIPS2 --> PSProfile2
    NAIPS3 --> PSProfile2
    
    PSProfile2 --> PP2A[Depressive Psychosis<br/>⬆️ Mood-Congruent Features]
    PSProfile2 --> PP2B[Psychomotor Retardation<br/>⬆️ Negative Symptoms]
    PSProfile2 --> PP2C[Cognitive Impairment<br/>⬆️ Confusion vs Hallucinations]
    PSProfile2 --> PP2D[Correlates with TSH<br/>Hormone-Dependent]
    PSProfile2 --> PP2E[Resolves with Treatment<br/>T4 Replacement Effective]
    
    NAIPS3 --> MM[Myxedema Madness<br/>Severe Hypothyroidism]
    
    MM --> MM1[Very High TSH<br/>>50-100 mIU/L]
    MM --> MM2[Severe Hypothyroid State<br/>Medical Emergency]
    MM --> MM3[Paranoid Delusions<br/>Hallucinations]
    MM --> MM4[Profound Cognitive Impairment]
    MM --> MM5[Responds to T4 Replacement<br/>+ Supportive Care]
    MM --> MM6[Gradual Onset<br/>Weeks to Months]
    
    %% Comparative Outcomes
    PSProfile1 --> Compare[Comparative Analysis]
    PSProfile2 --> Compare
    HE --> Compare
    MM --> Compare
    
    Compare --> Comp1[Psychosis Prevalence<br/>AI: 20-35% vs NAI: 7-15%<br/>Expected OR: 2.5-3.0]
    Compare --> Comp2[Symptom Severity<br/>AI: Higher BPRS Scores<br/>More Persistent]
    Compare --> Comp3[Symptom Type<br/>AI: Perceptual > Cognitive<br/>NAI: Cognitive > Perceptual]
    Compare --> Comp4[Treatment Response<br/>AI: May Need Immunotherapy<br/>NAI: T4 Usually Sufficient]
    Compare --> Comp5[Temporal Pattern<br/>AI: Can Occur with Normal TSH<br/>NAI: Correlates with Severity]
    Compare --> Comp6[Antibody Correlation<br/>AI: ⬆️ Anti-TPO = ⬆️ Symptoms<br/>NAI: No Antibody Association]
    
    %% Age-Dependent Differences
    Compare --> AgeDiff[Age-Dependent Patterns]
    
    AgeDiff --> Ped[Pediatric Population<br/>Ages 6-17]
    AgeDiff --> Adult[Adult Population<br/>Ages 18-65]
    
    Ped --> PedAI[Autoimmune Pediatric]
    Ped --> PedNAI[Non-Autoimmune Pediatric]
    
    PedAI --> PedAI1[Greater Neurodevelopmental Impact]
    PedAI --> PedAI2[School Performance Issues]
    PedAI --> PedAI3[Behavioral Changes]
    PedAI --> PedAI4[Attenuated Psychotic Symptoms<br/>Prevalence: 10-15%]
    
    PedNAI --> PedNAI1[Developmental Delays]
    PedNAI --> PedNAI2[Cognitive Slowing]
    PedNAI --> PedNAI3[Lower Psychosis Risk<br/>Prevalence: 3-5%]
    
    Adult --> AdAI[Autoimmune Adult]
    Adult --> AdNAI[Non-Autoimmune Adult]
    
    AdAI --> AdAI1[Complex Psychiatric Comorbidity]
    AdAI --> AdAI2[Treatment-Resistant Depression]
    AdAI --> AdAI3[Higher Psychosis Risk<br/>Prevalence: 25-35%]
    AdAI --> AdAI4[Hashimoto's Encephalopathy<br/>Peak Age: 40-60 years]
    
    AdNAI --> AdNAI1[Hormone-Responsive Symptoms]
    AdNAI --> AdNAI2[Moderate Depression/Anxiety]
    AdNAI --> AdNAI3[Lower Psychosis Risk<br/>Prevalence: 10-15%]
    
    %% Clinical Implications
    Comp1 --> ClinImp[Clinical Implications]
    Comp2 --> ClinImp
    Comp3 --> ClinImp
    Comp4 --> ClinImp
    Comp5 --> ClinImp
    Comp6 --> ClinImp
    
    ClinImp --> CI1[Screening Recommendations<br/>Enhanced Psychiatric Monitoring<br/>for Autoimmune Cases]
    ClinImp --> CI2[Treatment Strategies<br/>AI: Consider Immunotherapy<br/>NAI: Optimize T4 Replacement]
    ClinImp --> CI3[Prognostic Implications<br/>AI: More Persistent Symptoms<br/>NAI: Better Response to T4]
    ClinImp --> CI4[Biomarker Targets<br/>AI: Inflammatory/Immune Markers<br/>NAI: Metabolic Markers]
    
    CI1 --> End
    CI2 --> End
    CI3 --> End
    CI4 --> End
    
    End([Future Directions:<br/>Biomarker Discovery<br/>Personalized Treatment<br/>Mechanistic Studies])
    
    style Start fill:#e1f5e1
    style AI fill:#ffebee
    style NAI fill:#e3f2fd
    style Shared1 fill:#fff9c4
    style AIPsy fill:#ff5252,color:#fff
    style NAIPsy fill:#64b5f6,color:#fff
    style HE fill:#d32f2f,color:#fff
    style MM fill:#1976d2,color:#fff
    style PSProfile1 fill:#ef5350,color:#fff
    style PSProfile2 fill:#42a5f5,color:#fff
    style Compare fill:#f3e5f5
    style ClinImp fill:#c8e6c9
    style End fill:#e1f5e1
    style AIMech fill:#ffccbc
    style AgeDiff fill:#e1bee7